University of Southampton investigates Acerta ’s lymphoma drug

Researchers at the University of Southampton, UK, have initiated a clinical trial to evaluate Acerta Pharma ’s new product candidate acalabrutinib in combination with existing standard therapy called R-CHOP to treat select patients with diffuse large …
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news